474
Participants
Start Date
September 6, 2023
Primary Completion Date
August 15, 2025
Study Completion Date
November 30, 2025
Amniotic Suspension Allograft
This investigational product is a cryopreserved product derived from human amnion and cells from the amniotic fluid.
Placebo
Matching placebo is 0.9% normal saline: 4 mL to be injected IA.
NYU Langone Health, New York
Hospital for Special Surgery, New York
Northwell Health, New York
Upstate Clinical Research Associates, LLC, Williamsville
Lehigh Center for Clinical Research, Allentown
Sinai Hospital, Baltimore
Klein & Associates M.D., P.A., Hagerstown
Spectrum Medical, Inc., Danville
West Clinical Research, Morehead City
Clinical Trials of South Carolina, Charleston
Vista Clinical Research, Newnan
CenExcel/ACMR, Atlanta
AppleMed Research Group, LLC., Miami
Gulfcoast Research Institute, Sarasota
Central Research Associates, Inc., Birmingham
Alabama Clinical Therapeutics, LLC, Birmingham
The Ohio State University Wexner Medical Center, Columbus
MediSphere Medical Research Center, Evansville
Oakland Medical Research, Troy
Advanced Quality Medical Research, Inc, Orland Park
Chicago Clinical Research Institute Inc., Chicago
Rush University Medical Center, Chicago
Sundance Clinical Research, St Louis
Quality Clinical Research, Omaha
Physician Research Collaboriation, LLC, Lincoln
Conrad Clinical Research, Edmond
Tekton Research, Yukon
ClinRXResearch INC, Carrollton
Zenos Clinical Research, Dallas
Cedar Health Research, LLC, Burleson
Tekton Research, Austin
JBR Clinical Research, Salt Lake City
Fiel Family & Sports Medicine, Tempe
Dream Team Clinical Research, Pomona
Horizon Clinical Research, La Mesa
TriWest Research Associates, San Diego
Infinity Clinical Research, Norco
Stanford Medicine, Redwood City
Neurovations Research, Napa
Spokane Joint Replacement Center, Spokane
Skylight Health Research, Burlington
Lead Sponsor
Organogenesis
INDUSTRY